Literature DB >> 10764091

Molecular imaging of stretch-induced tissue factor expression in carotid arteries with intravascular ultrasound.

G M Lanza1, D R Abendschein, C S Hall, J N Marsh, M J Scott, D E Scherrer, S A Wickline.   

Abstract

RATIONALE AND
OBJECTIVES: Molecular imaging with targeted contrast agents enables tissues to be distinguished by detecting specific cell-surface receptors. In the present study, a ligand-targeted acoustic nanoparticle system is used to identify angioplasty-induced expression of tissue factor by smooth muscle cells within carotid arteries.
METHODS: Pig carotid arteries were overstretched with balloon catheters, treated with tissue factor-targeted or a control nanoparticle system, and imaged with intravascular ultrasound before and after treatment.
RESULTS: Tissue factor-targeted emulsions bound and increased the echogenicity and gray-scale levels of overstretched smooth muscle cells within the tunica media, versus no change in contralateral control arteries. Expression of stretch-induced tissue factor in carotid artery media was confirmed by immunohistochemistry.
CONCLUSIONS: The potential for abnormal thrombogenicity of balloon-injured arteries, as reflected by smooth muscle expression of tissue factor, was imaged using a novel, targeted, nanoparticulate ultrasonic contrast agent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10764091     DOI: 10.1097/00004424-200004000-00003

Source DB:  PubMed          Journal:  Invest Radiol        ISSN: 0020-9996            Impact factor:   6.016


  10 in total

Review 1.  Molecular imaging with targeted contrast ultrasound.

Authors:  Mark Piedra; Achim Allroggen; Jonathan R Lindner
Journal:  Cerebrovasc Dis       Date:  2009-04-16       Impact factor: 2.762

Review 2.  Perfluorocarbon nanoparticles for physiological and molecular imaging and therapy.

Authors:  Junjie Chen; Hua Pan; Gregory M Lanza; Samuel A Wickline
Journal:  Adv Chronic Kidney Dis       Date:  2013-11       Impact factor: 3.620

3.  Thrombin-inhibiting perfluorocarbon nanoparticles provide a novel strategy for the treatment and magnetic resonance imaging of acute thrombosis.

Authors:  J Myerson; L He; G Lanza; D Tollefsen; S Wickline
Journal:  J Thromb Haemost       Date:  2011-07       Impact factor: 5.824

4.  Magnetic Nanoparticles for Early Detection of Cancer by Magnetic Resonance Imaging.

Authors:  Wenbin Lin; Taeghwan Hyeon; Gregory M Lanza; Miqin Zhang; Thomas J Meade
Journal:  MRS Bull       Date:  2009-06       Impact factor: 6.578

Review 5.  Molecular imaging of atherosclerosis with nanoparticle-based fluorinated MRI contrast agents.

Authors:  Rohun U Palekar; Andrew P Jallouk; Gregory M Lanza; Hua Pan; Samuel A Wickline
Journal:  Nanomedicine (Lond)       Date:  2015       Impact factor: 5.307

Review 6.  Molecular imaging of cardiovascular disease using ultrasound.

Authors:  Flordeliza S Villanueva
Journal:  J Nucl Cardiol       Date:  2008 Jul-Aug       Impact factor: 5.952

7.  Intramural delivery of rapamycin with alphavbeta3-targeted paramagnetic nanoparticles inhibits stenosis after balloon injury.

Authors:  Tillmann Cyrus; Huiying Zhang; John S Allen; Todd A Williams; Grace Hu; Shelton D Caruthers; Samuel A Wickline; Gregory M Lanza
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-02-21       Impact factor: 8.311

8.  Drug packaging and delivery using perfluorocarbon nanoparticles for targeted inhibition of vascular smooth muscle cells.

Authors:  Zhao-xiong Zhou; Bai-gen Zhang; Hao Zhang; Xiao-zhong Huang; Ya-li Hu; Li Sun; Xiao-min Wang; Ji-wei Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-11       Impact factor: 6.150

9.  Application of a hemolysis assay for analysis of complement activation by perfluorocarbon nanoparticles.

Authors:  Christine T N Pham; Dennis G Thomas; Julia Beiser; Lynne M Mitchell; Jennifer L Huang; Angana Senpan; Grace Hu; Mae Gordon; Nathan A Baker; Dipanjan Pan; Gregory M Lanza; Dennis E Hourcade
Journal:  Nanomedicine       Date:  2013-11-08       Impact factor: 5.307

10.  Ultrasound imaging versus morphopathology in cardiovascular diseases. Coronary atherosclerotic plaque.

Authors:  Giorgio Baroldi; Riccardo Bigi; Lauro Cortigiani
Journal:  Cardiovasc Ultrasound       Date:  2004-12-14       Impact factor: 2.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.